Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

New forms of induction of apoptosis in aggressive lymphoma using peptides that interrupt the RAS / RAF interaction

Bergna C, Marin GH, Maiz M, Bruzzoni Giovanelli H, Ponzinibbio C, Schinella G, Errecalde J, Rebollo A.

Ceylon Med J. 2019 Jun 30;64(2):46-51.

2.

New Therapeutic Approach for Targeting Hippo Signalling Pathway.

Dominguez-Berrocal L, Cirri E, Zhang X, Andrini L, Marin GH, Lebel-Binay S, Rebollo A.

Sci Rep. 2019 Mar 18;9(1):4771. doi: 10.1038/s41598-019-41404-w.

3.

Correction to: T cell leukemia control via Ras-Raf pathway inhibition with peptides.

Marin GH, Rebollo A, Bruzzoni-Giovanelli H, Schinella G, Piazzon I, Duarte A, Errecalde J.

J Med Life. 2018 Jan-Mar;11(1):83.

4.

Identification and characterization of novel enhanced cell penetrating peptides for anti-cancer cargo delivery.

Zhang X, Brossas JY, Parizot C, Zini JM, Rebollo A.

Oncotarget. 2017 Dec 11;9(5):5944-5957. doi: 10.18632/oncotarget.23179. eCollection 2018 Jan 19.

5.

Peptides derived from Plasmodium falciparum leucine-rich repeat 1 bind to serine/threonine phosphatase type 1 and inhibit parasite growth in vitro.

Pierrot C, Zhang X, Zanghi G, Fréville A, Rebollo A, Khalife J.

Drug Des Devel Ther. 2018 Jan 9;12:85-88. doi: 10.2147/DDDT.S153095. eCollection 2018. No abstract available. Erratum in: Drug Des Devel Ther. 2018 Mar 29;12 :655. Zhangi, Gigliola [corrected to Zanghi, Gigliola].

6.

Interfering peptides targeting protein-protein interactions: the next generation of drugs?

Bruzzoni-Giovanelli H, Alezra V, Wolff N, Dong CZ, Tuffery P, Rebollo A.

Drug Discov Today. 2018 Feb;23(2):272-285. doi: 10.1016/j.drudis.2017.10.016. Epub 2017 Oct 31. Review.

PMID:
29097277
7.

T cell leukemia control via Ras-Raf pathway inhibition with peptides.

Marin GH, Rebollo A, Bruzzoni-Giovanelli H, Schinella G, Piazzon I, Duarte A, Errecalde J.

J Med Life. 2017 Jul-Sep;10(3):172-175. Erratum in: J Med Life. 2018 Jan-Mar;11(1):83.

8.

Evaluation of Caspase-9b and PP2Acα2 as potential biomarkers for chronic lymphocytic leukemia.

Domínguez-Berrocal L, Zhang X, Zini JM, Fominaya J, Rebollo A, Bravo J.

Biomark Res. 2016 May 4;4:9. doi: 10.1186/s40364-016-0063-6. eCollection 2016.

9.

Strategies to stabilize cell penetrating peptides for in vivo applications.

Fominaya J, Bravo J, Rebollo A.

Ther Deliv. 2015;6(10):1171-94. doi: 10.4155/tde.15.51. Epub 2015 Oct 8. Review.

PMID:
26448473
10.

Enhanced serum proteolysis resistance of cell-penetrating peptides.

Fominaya J, Bravo J, Decaudin D, Brossa JY, Nemati F, Rebollo A.

Ther Deliv. 2015 Feb;6(2):139-47. doi: 10.4155/tde.14.100.

PMID:
25690083
11.

Cell penetrating peptides as a therapeutic strategy in chronic lymphocytic leukemia.

Arrouss I, Decaudin D, Choquet S, Azar N, Parizot C, Zini JM, Nemati F, Rebollo A.

Protein Pept Lett. 2015;22(6):539-46.

PMID:
25687226
12.

P. falciparum isolate-specific distinct patterns of induced apoptosis in pulmonary and brain endothelial cells.

N'Dilimabaka N, Taoufiq Z, Zougbédé S, Bonnefoy S, Lorthiois A, Couraud PO, Rebollo A, Snounou G, Mazier D, Moreno Sabater A.

PLoS One. 2014 Mar 31;9(3):e90692. doi: 10.1371/journal.pone.0090692. eCollection 2014.

13.

Liquid fructose down-regulates liver insulin receptor substrate 2 and gluconeogenic enzymes by modifying nutrient sensing factors in rats.

Rebollo A, Roglans N, Baena M, Padrosa A, Sánchez RM, Merlos M, Alegret M, Laguna JC.

J Nutr Biochem. 2014 Feb;25(2):250-8. doi: 10.1016/j.jnutbio.2013.10.014. Epub 2013 Nov 22.

14.

Liquid fructose downregulates Sirt1 expression and activity and impairs the oxidation of fatty acids in rat and human liver cells.

Rebollo A, Roglans N, Baena M, Sánchez RM, Merlos M, Alegret M, Laguna JC.

Biochim Biophys Acta. 2014 Apr 4;1841(4):514-24. doi: 10.1016/j.bbalip.2014.01.002. Epub 2014 Jan 13.

15.

[Use of ocular drugs in pregnancy].

Arruti N, Rebollo A, Mezquita G, Alcaine A, Andonegui J.

An Sist Sanit Navar. 2013 Sep-Dec;36(3):479-87. Review. Spanish.

16.

Specific targeting of caspase-9/PP2A interaction as potential new anti-cancer therapy.

Arrouss I, Nemati F, Roncal F, Wislez M, Dorgham K, Vallerand D, Rabbe N, Karboul N, Carlotti F, Bravo J, Mazier D, Decaudin D, Rebollo A.

PLoS One. 2013 Apr 23;8(4):e60816. doi: 10.1371/journal.pone.0060816. Print 2013.

17.

Electrospinning of peptide and protein fibres: approaching the molecular scale.

Nuansing W, Frauchiger D, Huth F, Rebollo A, Hillenbrand R, Bittner AM.

Faraday Discuss. 2013;166:208-21.

PMID:
24611278
18.

Way back for fructose and liver metabolism: bench side to molecular insights.

Rebollo A, Roglans N, Alegret M, Laguna JC.

World J Gastroenterol. 2012 Dec 7;18(45):6552-9. doi: 10.3748/wjg.v18.i45.6552. Review.

19.

Cerebral malaria: what is known and what is on research.

Gay F, Zougbédé S, N'dilimabaka N, Rebollo A, Mazier D, Moreno A.

Rev Neurol (Paris). 2012 Mar;168(3):239-56. doi: 10.1016/j.neurol.2012.01.582. Epub 2012 Mar 2. Review.

PMID:
22386676
20.
21.

CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis.

Février M, Dorgham K, Rebollo A.

Viruses. 2011 May;3(5):586-612. doi: 10.3390/v3050586. Epub 2011 May 12. Review.

22.

Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions.

Pou J, Martínez-González J, Rebollo A, Rodríguez C, Rodríguez-Calvo R, Martín-Fuentes P, Cenarro A, Civeira F, Laguna JC, Alegret M.

Biochim Biophys Acta. 2011 Sep;1811(9):556-63. doi: 10.1016/j.bbalip.2011.05.014. Epub 2011 Jun 12.

PMID:
21683158
23.

Tissue factor pathway inhibitor 2 is induced by thrombin in human macrophages.

Pou J, Rebollo A, Piera L, Merlos M, Roglans N, Laguna JC, Alegret M.

Biochim Biophys Acta. 2011 Jun;1813(6):1254-60. doi: 10.1016/j.bbamcr.2011.03.020. Epub 2011 Apr 15.

24.

Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage.

Taoufiq Z, Pino P, N'dilimabaka N, Arrouss I, Assi S, Soubrier F, Rebollo A, Mazier D.

Malar J. 2011 Feb 28;10:52. doi: 10.1186/1475-2875-10-52.

25.

Deregulation of Aiolos expression in chronic lymphocytic leukemia is associated with epigenetic modifications.

Billot K, Soeur J, Chereau F, Arrouss I, Merle-Béral H, Huang ME, Mazier D, Baud V, Rebollo A.

Blood. 2011 Feb 10;117(6):1917-27. doi: 10.1182/blood-2010-09-307140. Epub 2010 Dec 7.

PMID:
21139082
26.

Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment.

Vilà L, Rebollo A, Ađalsteisson GS, Alegret M, Merlos M, Roglans N, Laguna JC.

Toxicol Appl Pharmacol. 2011 Feb 15;251(1):32-40. doi: 10.1016/j.taap.2010.11.011. Epub 2010 Nov 29.

PMID:
21122807
27.

Metabolic acidosis induced by Plasmodium falciparum intraerythrocytic stages alters blood-brain barrier integrity.

Zougbédé S, Miller F, Ravassard P, Rebollo A, Cicéron L, Couraud PO, Mazier D, Moreno A.

J Cereb Blood Flow Metab. 2011 Feb;31(2):514-26. doi: 10.1038/jcbfm.2010.121. Epub 2010 Aug 4.

28.

Differential aiolos expression in human hematopoietic subpopulations.

Billot K, Parizot C, Arrouss I, Mazier D, Debre P, Rogner UC, Rebollo A.

Leuk Res. 2010 Mar;34(3):289-93. doi: 10.1016/j.leukres.2009.05.016. Epub 2009 Jun 21.

PMID:
19540588
29.

Ritonavir increases CD36, ABCA1 and CYP27 expression in THP-1 macrophages.

Pou J, Rebollo A, Roglans N, Sánchez RM, Vázquez-Carrera M, Laguna JC, Pedro-Botet J, Alegret M.

Exp Biol Med (Maywood). 2008 Dec;233(12):1572-82. doi: 10.3181/0805-RM-144. Epub 2008 Oct 10.

PMID:
18849545
30.

Study protocol for a pragmatic randomised controlled trial in general practice investigating the effectiveness of acupuncture against migraine.

Vas J, Rebollo A, Perea-Milla E, Méndez C, Font CR, Gómez-Río M, Martín-Avila M, Carbrera-Iboleón J, Caballero MD, Olmos MA, Aguilar I, Faus V, Martos F.

BMC Complement Altern Med. 2008 Apr 14;8:12. doi: 10.1186/1472-6882-8-12.

31.

Differential epigenetic regulation of Aiolos expression in human tumoral cell lines and primary cells.

Duhamel M, Navarro P, Cario-Andre M, Billot K, Arrouss I, Rebollo A.

FEBS Lett. 2008 Feb 6;582(3):457-67. doi: 10.1016/j.febslet.2008.01.010. Epub 2008 Jan 17.

32.

The Aiolos transcription factor is up-regulated in chronic lymphocytic leukemia.

Duhamel M, Arrouss I, Merle-Béral H, Rebollo A.

Blood. 2008 Mar 15;111(6):3225-8. doi: 10.1182/blood-2007-09-113191. Epub 2008 Jan 9.

PMID:
18184862
33.

IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis.

Kreymborg K, Etzensperger R, Dumoutier L, Haak S, Rebollo A, Buch T, Heppner FL, Renauld JC, Becher B.

J Immunol. 2007 Dec 15;179(12):8098-104.

34.

Cascade of transcriptional induction and repression during IL-2 deprivation-induced apoptosis.

Fleischer A, Duhamel M, Lopez-Fernandez LA, Muñoz M, Rebollo MP, Alvarez-Franco F, Rebollo A.

Immunol Lett. 2007 Sep 15;112(1):9-29. Epub 2007 Jul 24. Erratum in: Immunol Lett. 2009 Jun 4;124(2):112-3.

PMID:
17651815
35.

Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study.

Minguez-Castellanos A, Chamorro CE, Escamilla-Sevilla F, Ortega-Moreno A, Rebollo AC, Gomez-Rio M, Concha A, Munoz DG.

Neurology. 2007 Jun 5;68(23):2012-8.

PMID:
17548551
36.

Critical function of Ikaros in controlling Aiolos gene expression.

Ghadiri A, Duhamel M, Fleischer A, Reimann A, Dessauge F, Rebollo A.

FEBS Lett. 2007 Apr 17;581(8):1605-16. Epub 2007 Mar 20. Erratum in: FEBS Lett. 2009 May 6;583(9):1554.

37.

Biological profile of new apoptotic agents based on 2,4-pyrido[2,3-d]pyrimidine derivatives.

Cordeu L, Cubedo E, Bandrés E, Rebollo A, Sáenz X, Chozas H, Victoria Domínguez M, Echeverría M, Mendivil B, Sanmartin C, Palop JA, Font M, García-Foncillas J.

Bioorg Med Chem. 2007 Feb 15;15(4):1659-69. Epub 2006 Dec 12.

PMID:
17204425
38.

DNA microdevice for electrochemical detection of Escherichia coli 0157:H7 molecular markers.

Berganza J, Olabarria G, García R, Verdoy D, Rebollo A, Arana S.

Biosens Bioelectron. 2007 Apr 15;22(9-10):2132-7. Epub 2006 Nov 2.

PMID:
17084071
39.

The toxofilin-actin-PP2C complex of Toxoplasma: identification of interacting domains.

Jan G, Delorme V, David V, Revenu C, Rebollo A, Cayla X, Tardieux I.

Biochem J. 2007 Feb 1;401(3):711-9.

40.

Identification of PP1alpha as a caspase-9 regulator in IL-2 deprivation-induced apoptosis.

Dessauge F, Cayla X, Albar JP, Fleischer A, Ghadiri A, Duhamel M, Rebollo A.

J Immunol. 2006 Aug 15;177(4):2441-51.

41.

A PKA survival pathway inhibited by DPT-PKI, a new specific cell permeable PKA inhibitor, is induced by T. annulata in parasitized B-lymphocytes.

Guergnon J, Dessauge F, Traincard F, Cayla X, Rebollo A, Bost PE, Langsley G, Garcia A.

Apoptosis. 2006 Aug;11(8):1263-73.

PMID:
16761111
42.

New symmetrical quinazoline derivatives selectively induce apoptosis in human cancer cells.

Cubedo E, Cordeu L, Bandres E, Rebollo A, Malumbres R, Sanmartin C, Font M, Palop JA, Gacía-Foncillas J.

Cancer Biol Ther. 2006 Jul;5(7):850-9. Epub 2006 Jul 22.

PMID:
16760648
43.

Use of penetrating peptides interacting with PP1/PP2A proteins as a general approach for a drug phosphatase technology.

Guergnon J, Dessauge F, Dominguez V, Viallet J, Bonnefoy S, Yuste VJ, Mercereau-Puijalon O, Cayla X, Rebollo A, Susin SA, Bost PE, Garcia A.

Mol Pharmacol. 2006 Apr;69(4):1115-24. Epub 2005 Dec 30.

PMID:
16387795
44.

Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes.

Llaverias G, Rebollo A, Pou J, Vázquez-Carrera M, Sánchez RM, Laguna JC, Alegret M.

Biochem Pharmacol. 2006 Feb 28;71(5):605-14. Epub 2006 Jan 18.

PMID:
16386711
45.

Modulating apoptosis as a target for effective therapy.

Fleischer A, Ghadiri A, Dessauge F, Duhamel M, Rebollo MP, Alvarez-Franco F, Rebollo A.

Mol Immunol. 2006 Mar;43(8):1065-79. Epub 2005 Aug 15. Review.

PMID:
16099509
46.

Association between bone mineral density and polymorphisms of the VDR, ERalpha, COL1A1 and CTR genes in Spanish postmenopausal women.

Bandrés E, Pombo I, González-Huarriz M, Rebollo A, López G, García-Foncillas J.

J Endocrinol Invest. 2005 Apr;28(4):312-21.

PMID:
15966503
47.

Bad-dependent rafts alteration is a consequence of an early intracellular signal triggered by interleukin-4 deprivation.

Fleischer A, Ghadiri A, Dessauge F, Duhamel M, Cayla X, Garcia A, Rebollo A.

Mol Cancer Res. 2004 Dec;2(12):674-84.

48.

[Lung scintigraphy with technetium 99m depreotide in the assessment of solitary pulmonary nodules].

Rebollo AC, Jiménez-Hoyuela JM, Martínez del Valle MD, Fernández Aguirre C, Soria C, Velasco JL.

Arch Bronconeumol. 2004 Nov;40(11):534-6. Spanish.

49.

New insights in protein phosphorylation: a signature for protein phosphatase 1 interacting proteins.

Garcia A, Cayla X, Caudron B, Deveaud E, Roncal F, Rebollo A.

C R Biol. 2004 Feb;327(2):93-7.

PMID:
15060979
50.

[Early alterations of adrenergic cardiac function in Parkinson's disease].

Campos V, Rebollo AC, Jiménez-Hoyuela JM, Gómez-Doblas JJ, Medialdea P, Vila E, Gutiérrez-Hurtado A.

Neurologia. 2004 Mar;19(2):53-8. Spanish.

PMID:
14986180

Supplemental Content

Loading ...
Support Center